Rosacea Support Community

so Galderma appears to be now designating Sansrosa as CD07805/47.

Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea

The clinical trials site is listing a dose finding trial for a topical gel that treats the redness of rosacea.

Even though the site doesn't mention COL-118 or Sansrosa by name it is clear that this is the final stages of the approval process for Sansrosa.

The aim of the trial is find the dosages that will be released to the public. Based on the efficacy of 3 strenghts, vs. just the vehicle gel Galderma will make a final application to gain approval for Sansrosa (or whatever they end up calling it).

I would imagine that sansrosa is a very tempting name as it is cute and smart and would be perfect for their branding.

Read more about Sansrosa, my extensive ongoing...

[ Continued ]